Ross et al. reported decreased bone formation, decreased osteocalcin expression and increased sclerostin RNA expression in young and old HFD-fed mice compared to standard chow-fed mice, confirming the negative effect exerted by metabolic diseases on bone, including through the activation of sclerostin [49]. This evidence concerns the gene SOST and metabolic disease.